LLS (Leukemia & Lymphoma Society) Sustainability Profile
The Leukemia & Lymphoma Society (LLS), headquartered in the United States, is a leading non-profit organisation dedicated to funding research and providing support for patients affected by blood cancers, including leukemia, lymphoma, and myeloma. Founded in 1949, LLS has made significant strides in advancing treatments and improving patient outcomes, with notable milestones such as the development of targeted therapies and immunotherapies. Operating across major regions in the US, LLS offers a range of core services, including patient education, financial assistance, and advocacy for blood cancer research funding. What sets LLS apart is its commitment to investing in innovative research and its comprehensive support network for patients and families. With a strong market position, LLS has raised billions for research and has played a pivotal role in increasing survival rates for blood cancer patients, making it a vital resource in the fight against these diseases.
DitchCarbon Score
How does LLS (Leukemia & Lymphoma Society)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Membership Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LLS (Leukemia & Lymphoma Society)'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LLS (Leukemia & Lymphoma Society)'s reported carbon emissions
The Leukemia & Lymphoma Society (LLS), headquartered in the US, currently does not have available data on its carbon emissions, as indicated by the absence of specific emissions figures. Consequently, there are no reported Scope 1, 2, or 3 emissions data or any significant reduction targets or achievements at this time. LLS has not outlined any specific climate commitments or initiatives aimed at reducing carbon emissions. Without concrete data or established targets, it is challenging to assess their environmental impact or progress in sustainability efforts. As the organisation continues to operate, it may consider developing a framework for measuring and reporting its carbon footprint, aligning with industry standards and best practices in climate action.
How Carbon Intensive is LLS (Leukemia & Lymphoma Society)'s Industry?
How Carbon Intensive is LLS (Leukemia & Lymphoma Society)'s Location?
LLS (Leukemia & Lymphoma Society)'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LLS (Leukemia & Lymphoma Society) has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
